Literature DB >> 9878810

Isolation and characterization of the gene coding for human cytidine deaminase.

S Demontis1, M Terao, M Brivio, S Zanotta, M Bruschi, E Garattini.   

Abstract

The human gene coding for cytidine deaminase (CD), the enzyme which catalyzes the deamination of cytidine and deoxycytidine to uridine and deoxyuridine, was isolated and structurally characterized. CD is a single copy gene with a length of 31 kb and consists of four exons. Exon-intron junctions do not bracket functional domains of the encoded protein as the boundary between exons 2 and 3 interrupts the catalytically important zinc-finger domain, which is well conserved along phylogenesis. 5'-RACE and RNase mapping experiments identify one major and multiple other minor transcription initiation sites, which are present in placenta as well as in the myeloid cell lines, HL-60 and U937. The 5'-flanking region of the gene contains an orientation-dependent functional promoter and is characterized by the presence of several potential sites for the binding of known transcriptional factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878810     DOI: 10.1016/s0167-4781(98)00235-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?

Authors:  Audrey Frances; Pierre Cordelier
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

2.  Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.

Authors:  Jan Gerard Maring; Floris M Wachters; Monique Slijfer; J Marina Maurer; H Marike Boezen; Donald R A Uges; Elisabeth G E de Vries; Harry J M Groen
Journal:  Eur J Clin Pharmacol       Date:  2010-03-06       Impact factor: 2.953

3.  Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation.

Authors:  Beata Hryciuk; Bartosz Szymanowski; Anna Romanowska; Ewa Salt; Bartosz Wasąg; Bartłomiej Grala; Jacek Jassem; Renata Duchnowska
Journal:  Oncol Lett       Date:  2017-11-22       Impact factor: 2.967

4.  Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.

Authors:  Sara M Fitzgerald; Rakesh K Goyal; William R A Osborne; Jennifer D Roy; John W Wilson; R E Ferrell
Journal:  Hum Genet       Date:  2006-01-31       Impact factor: 4.132

5.  Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.

Authors:  Runqiu Yi; Liying Xie; Xiaoqing Wang; Chengpin Shen; Xiaojun Chen; Liang Qiao
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

6.  Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus.

Authors:  Danielle Malheiros; Rodrigo A Panepucci; Ana M Roselino; Amélia G Araújo; Marco A Zago; Maria Luiza Petzl-Erler
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

7.  Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.

Authors:  Hamza Mameri; Ivan Bièche; Didier Meseure; Elisabetta Marangoni; Géraldine Buhagiar-Labarchède; André Nicolas; Sophie Vacher; Rosine Onclercq-Delic; Vinodh Rajapakse; Sudhir Varma; William C Reinhold; Yves Pommier; Mounira Amor-Guéret
Journal:  Clin Cancer Res       Date:  2016-09-06       Impact factor: 12.531

8.  Complete Genome Sequence of Serratia marcescens Siphophage Serbin.

Authors:  Eric A Williams; Helena Hopson; Andrea Rodriguez; Rohit Kongari; Rachele Bonasera; Adriana C Hernandez-Morales; Mei Liu
Journal:  Microbiol Resour Announc       Date:  2019-05-09

9.  RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.

Authors:  Ajay Abraham; Savitha Varatharajan; Sreeja Karathedath; Chepsy Philip; Kavitha M Lakshmi; Ashok Kumar Jayavelu; Ezhilpavai Mohanan; Nancy Beryl Janet; Vivi M Srivastava; Ramachandran V Shaji; Wei Zhang; Aby Abraham; Auro Viswabandya; Biju George; Mammen Chandy; Alok Srivastava; Vikram Mathews; Poonkuzhali Balasubramanian
Journal:  Pharmacogenomics       Date:  2015-06-17       Impact factor: 2.533

10.  Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.

Authors:  C Bengala; V Guarneri; E Giovannetti; M Lencioni; E Fontana; V Mey; A Fontana; U Boggi; M Del Chiaro; R Danesi; S Ricci; F Mosca; M Del Tacca; P F Conte
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.